In a patient with an ulcerative colitis flare who is hypotensive and taking a monoamine oxidase inhibitor (phenelzine) and lithium, how should fluid resuscitation, blood pressure management, and medication adjustments be handled?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Ulcerative Colitis Flare with Hypotension in a Patient on Phenelzine and Lithium

In a hypotensive patient with an ulcerative colitis flare taking phenelzine (MAOI) and lithium, immediate aggressive fluid resuscitation with crystalloids should begin while simultaneously discontinuing phenelzine due to its propensity to cause severe orthostatic hypotension, and preparing for emergency surgical intervention if the patient remains hemodynamically unstable despite resuscitation.

Immediate Fluid Resuscitation

The hypotensive UC patient requires urgent volume restoration regardless of medication complications. Begin immediate IV crystalloid resuscitation with at least 30 mL/kg within the first 3 hours 1. Target a mean arterial pressure ≥65 mmHg 1. For patients with acute severe ulcerative colitis and hemodynamic instability, emergency surgical exploration according to damage control principles is mandatory 2.

Resuscitation Goals

  • Mean arterial pressure ≥65 mmHg
  • Urine output ≥0.5 mL/kg/hr
  • Normalization of heart rate and blood pressure
  • Hemoglobin >7 g/dL (>9 g/dL if massive bleeding or cardiovascular comorbidities) 2

Frequent reassessment of hemodynamic status is essential, including heart rate, blood pressure, urine output, and clinical signs of perfusion 1. If the patient fails to respond to initial fluid boluses, this represents hemorrhagic shock requiring immediate surgical intervention 2.

Critical Medication Management: Phenelzine

Phenelzine must be discontinued immediately in this hypotensive patient. The FDA label explicitly warns that phenelzine causes postural hypotension as a common adverse effect 3 and should be used with extreme caution in combination with antihypertensive drugs, as exaggerated hypotensive effects may result 3.

Key Phenelzine Considerations:

  • Phenelzine commonly causes orthostatic hypotension, which will be severely exacerbated by the hypovolemia from UC bleeding 3, 4
  • The drug can cause both hypertensive crises (paradoxically) and severe hypotension 3
  • Phenelzine's effects persist for 2 weeks after discontinuation due to irreversible MAO inhibition 3
  • Research demonstrates phenelzine increases pressor sensitivity to tyramine 15.7-fold, with effects lasting more than 8 weeks after withdrawal 5

Vasopressor Caution:

If vasopressors become necessary for persistent hypotension despite fluid resuscitation, extreme caution is required because phenelzine can cause unpredictable interactions with sympathomimetic agents. The patient may exhibit either exaggerated hypotensive responses or paradoxical hypertensive crises 3. If pressors are needed, start with the lowest possible doses and titrate carefully.

Lithium Management

Lithium levels must be monitored closely during aggressive fluid resuscitation. Volume depletion and aggressive diuresis can increase lithium levels to toxic ranges, while rapid fluid administration may dilute levels. Check lithium levels immediately and every 12-24 hours during the acute phase. Hold lithium doses if the patient develops acute kidney injury (monitor creatinine twice daily during IV diuretic use) 6.

Surgical Decision-Making Algorithm

The 2021 WSES-AAST guidelines provide clear surgical indications 2:

Immediate Surgery Required:

  1. Hemodynamically unstable patients non-responsive to resuscitation (strong recommendation, 1C) 2
  2. Hemorrhagic shock with ongoing bleeding 2
  3. Colonic perforation with peritonitis 2
  4. Toxic megacolon with perforation, massive bleeding, or clinical deterioration 2

Urgent Surgery (within 24-48 hours):

  1. Persistent hemodynamic instability despite adequate fluid resuscitation 2
  2. Massive colorectal hemorrhage non-responsive to medical treatment 2
  3. Toxic megacolon without clinical improvement after 24-48 hours of medical treatment 2
  4. Increasing transfusion requirements 2

Subtotal colectomy with ileostomy is the surgical treatment of choice for acute severe UC with massive hemorrhage or hemodynamic instability (strong recommendation, 1A) 2.

Medical Management During Stabilization

If the patient achieves hemodynamic stability after initial resuscitation:

Corticosteroids:

  • Intravenous corticosteroids are first-line for hemodynamically stable acute severe UC 2
  • Assess response by day 3 2
  • However, do not delay surgery for steroid trials in unstable patients 2

Antibiotics:

  • Administer empiric broad-spectrum antibiotics covering gram-negative aerobes, gram-positive streptococci, and anaerobes if superinfection or abscess is suspected 2
  • All fevers should trigger neutropenic fever protocols with empiric antibiotics 7

Nutritional Support:

  • Total parenteral nutrition is mandatory for emergency surgery in complicated IBD 2
  • Critical for severely undernourished patients 2

Common Pitfalls to Avoid

  1. Do not delay surgery waiting for medical therapy to work in hemodynamically unstable patients - mortality increases significantly with delayed intervention 2
  2. Do not continue phenelzine during acute hypotension - the orthostatic effects will compound hypovolemic shock 3
  3. Do not use standard vasopressor dosing without considering MAOI interactions - unpredictable responses may occur 3
  4. Do not forget that phenelzine's effects persist for 2+ weeks after discontinuation - dietary restrictions and drug interactions remain relevant 3
  5. Do not neglect lithium monitoring during fluid shifts - both volume depletion and aggressive resuscitation affect levels

Monitoring Requirements

  • Blood pressure and heart rate: continuously initially, then every 15-30 minutes
  • Urine output: hourly
  • Hemoglobin/hematocrit: every 4-6 hours if bleeding
  • Electrolytes, creatinine: twice daily during active resuscitation 6
  • Lithium level: immediately, then every 12-24 hours
  • Clinical reassessment: every 1-2 hours until stable, then every 4-6 hours 2

The key principle is that hemodynamic instability in acute severe UC mandates emergency surgery 2. Medical optimization including phenelzine discontinuation and careful medication management should occur simultaneously with, not instead of, preparation for surgical intervention.

Related Questions

What is the appropriate treatment regimen for an ulcerative colitis flare?
Is orphenadrine safe for use in a patient with stable ulcerative colitis?
What is the recommended treatment for acute severe ulcerative colitis?
What are the recommended pharmacologic treatments for ulcerative colitis in adults, including dosing regimens?
Which steroid should be initiated for severe ulcerated ulcerative colitis managed as an outpatient?
What is the recommended management for a patient with ADHD and treatment‑resistant schizophrenia who is currently taking a monoamine‑oxidase inhibitor (MAOI) and lithium?
Can hydroxyzine be used short‑term for insomnia in an adult patient who has no contraindications such as severe hepatic impairment, narrow‑angle glaucoma, urinary retention, hypersensitivity, pregnancy, or nursing?
What is the recommended management for a patient with treatment‑resistant depression (not schizophrenia) who is currently on a monoamine oxidase inhibitor (MAOI) and lithium?
What is COPD, including its etiology, risk factors, symptoms, diagnostic criteria, and treatment recommendations for Canadian physicians?
What is the assessment and plan for a patient with hepatic encephalopathy secondary to liver cirrhosis who is listed for liver transplantation and has a history of type 1 diabetes mellitus and bipolar disorder?
In a patient with bipolar I disorder experiencing low mood, irritability, relationship conflict, and irregular sleep who worsened on aripiprazole (Abilify), what is the recommended next pharmacologic management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.